AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Protara Therapeutics, Inc. Director's Dealing 2020

Jan 13, 2020

34057_dirs_2020-01-13_264133c8-7144-483b-b66e-f40d6e17524f.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ArTara Therapeutics, Inc. (TARA)
CIK: 0001359931
Period of Report: 2020-01-09

Reporting Person: Opaleye, L.P. (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4603	Direct

Footnotes

F1: The shares reported reflect on a post 1-for-40 reverse stock split of the Issuer's Common Stock, effected on January 9, 2020.